dc.contributor.advisor | Kabir, Eva Rahman | |
dc.contributor.advisor | Hossain, M. Zulfiquer | |
dc.contributor.author | Fred, Namanda Rogers | |
dc.date.accessioned | 2021-09-15T17:11:53Z | |
dc.date.available | 2021-09-15T17:11:53Z | |
dc.date.copyright | 2021 | |
dc.date.issued | 2021-05 | |
dc.identifier.other | ID: 17146061 | |
dc.identifier.uri | http://hdl.handle.net/10361/15018 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. | en_US |
dc.description | Cataloged from PDF version of thesis report. | |
dc.description | Includes bibliographical references (pages 74-87). | |
dc.description.abstract | This review examines and summarizes major novel immunotherapeutic modalities used in
cancer immunotherapy that are currently approved or in clinical trials, as well as their
therapeutic potential, side effects, challenges, and future directions The aim of this study was
to show different immunotherapeutic modalities used to treat cancer. The mechanism of
action of the immune system to combat cancer e.g. Adoptive T cell transfer therapy (TIL,
TCR, CAR T Cells), Immune checkpoint inhibitors, monoclonal antibodies cancer vaccines,
cytokines and enzyme therapeutic. Second, the study aims to create awareness and provide
hope to cancer patients as well as to academics interested in learning more about
immunotherapy. Immunotherapy has shown great potential and promise in the treatment of a
variety of cancers like solid tumors and hematologic malignancies. Finally, it discusses
immunotherapy treatment prospects in the future, including combination therapy. | en_US |
dc.description.statementofresponsibility | Namanda Rogers Fred | |
dc.format.extent | 87 Pages | |
dc.language.iso | en_US | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Immunotherapy | en_US |
dc.subject | TIL | en_US |
dc.subject | TCR | en_US |
dc.subject | CAR T Cells | en_US |
dc.subject | Monoclonal antibodies | en_US |
dc.subject | Checkpoint inhibitors | en_US |
dc.title | Immunotherapeutic approaches to treat cancer: Prospects and challenges | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Department of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |